USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark AVIMER was filed as Word mark on 07/26/2006 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".
| Trademark form | Word mark |
| File reference | 78937975 |
| Application date | July 26, 2006 |
| Publication date | September 30, 2008 |
Trademark owner
2450 Bayshore Parkway
94043 Mountain View
US
94043 Mountain View
US
Trademark representatives
goods and services
1
Chemical additives for use in the manufacture of pharmaceuticals
5
Recombinant peptides with high avidity for binding with particular protein targets for the purpose of treating mammalian diseases, namely, inflammatory, immunological, rheumatological, neurological, oncological, hematological, urological, nephrological, metabolic, endocrinological, pulmonary, cardiovascular, musculoskeletal, infectious, ophthalmological, otolaryngological, neoplastic, autoimmune and renal diseases, for use in the treatment of loss of bone mass, chronic anemia, hyperparathyroidism, hypercalcemia, bone metabolism related diseases and disorders, human immune diseases and conditions, viral infections, injury to epithelial cells and tissues, obesity, diabetes, hypertension, dyslipidemia, infertility, surgical or soft tissue damage and injury to epithelial cells and tissues, for use in stimulating production of red blood cells, white blood cells, platelets and platelet precursor cells, for modulating calcium, phosphorous, or parathyroid hormone levels in the blood, and for use in anticancer and antiviral applications, modulating weight loss, regulating reproductive function, promoting wound healing, preventing the loss of bone mass, restoring the level of white blood cells, promoting growth and differentiation of neurons and preventing neuronal death
ID: 1378937975